Stay updated with breaking news from வேந்ரைட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Annovis Bio, Inc.: Annovis Bio to Present at the H.C. Wainwright Global Life Sciences Conference Berwyn, Pennsylvania (Newsfile Corp. - March 9, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced that Maria Maccecchini, Ph.D., Founder and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference. Annovis Bio s presentation will be available online beginning March 9, 2021 at 7:00 a.m. ET., and the presentation will be archived and available for replay for 90 days after the event. The register and view the webcast, visit: https://journey.ct.events/view/f6675119-df47-4bf8-8553-6891b8fb3ee4 ....
DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021. A webcast of the presentation at the H.C. Wainwright Healthcare Conference will be available on the Investors & Media section of the Company s website beginning Tuesday, March 9 th at 7:00 a.m. ET: ....
ObsEva SA: ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference Geneva, Switzerland and Boston, MA - March 3, 2021 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women s reproductive health, today announced that Company Management will provide a corporate update and participate in one-on-one investor meetings at the upcoming H.C. Wainwright Global Life Sciences Conference to be held March 9-10, 2021. The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. EST on Tuesday, March 9, 2021. ObsEva webcast link [ here] The presentation and archived webcast will also be accessible under Events Calendar in the investors section of ObsEva s [ ....
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference FRAMINGHAM, MA / ACCESSWIRE / March 3, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ( Xenetic or the Company ), a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021. In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website here. ....
Neovasc Inc.: Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - March 3, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 2021 H.C. Wainwright Global Life Sciences Conference that is scheduled to take place March 9-10, 2021. A recorded presentation by Bill Little, Neovasc s Chief Operating Officer, will be available on the Conference website starting at 7:00 am EST on March 9. Company management will also be scheduling one-on-one meetings with investors; meetings may be requested through H.C. Wainwright. A link to the recorded presentation will also be available in the investor relations section of the Neovasc website at https://www.neovasc.com/investors/. ....